Shockwave Medical (Shockwave Medical) Interest Expense : $-9.2 Mil (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Shockwave Medical Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Shockwave Medical's interest expense for the three months ended in Mar. 2024 was $ -2.9 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-9.2 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Shockwave Medical's Operating Income for the three months ended in Mar. 2024 was $ 42.4 Mil. Shockwave Medical's Interest Expense for the three months ended in Mar. 2024 was $ -2.9 Mil. Shockwave Medical's Interest Coverage for the quarter that ended in Mar. 2024 was 14.41. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shockwave Medical Interest Expense Historical Data

The historical data trend for Shockwave Medical's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shockwave Medical Interest Expense Chart

Shockwave Medical Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.94

-1.21

-1.10

-1.89

-6.91

Shockwave Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-0.64	-0.81	-2.51	-2.95	-2.94

Shockwave Medical Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.2 Mil.

Shockwave Medical (NAS:SWAV) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shockwave Medical's Interest Expense for the three months ended in Mar. 2024 was $-2.9 Mil. Its Operating Income for the three months ended in Mar. 2024 was $42.4 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $773.1 Mil.

Shockwave Medical's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	42.407	/	-2.943
	=	14.41

The higher the ratio, the stronger the company's financial strength is.

Shockwave Medical (Shockwave Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shockwave Medical Inc (NAS:SWAV) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

36M:Germany 36M:Germany

Address

5403 Betsy Ross Drive, Santa Clara, CA, USA, 95054

Website

https://www.shockwavemedical.com

ShockWave Medical Inc is a medical device company focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Its intravascular lithotripsy technology is used in the treatment of calcified plaque. Geographically, the company generates its revenue from the United States, Europe and other countries.

Executives

Douglas Evan Godshall	director, officer: President & CEO	SUITE 4 LEVEL 46 2 PARK STREET, SIDNEY C3 2000
Frank T Watkins	director	5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Isaac Zacharias	officer: Chief Commercial Officer	5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Dan Puckett	officer: CFO & Secretary	5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Trinh Phung	officer: VP, Finance	C/O SHOCKWAVE MEDICAL, INC., 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Laura Francis	director	C/O SI-BONE, INC., 471 EL CAMINO REAL, SUITE 101, SANTA CLARA CA 95050
Sara Toyloy	director	C/O SHOCKWAVE MEDICAL, INC., 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Kevin J. Ballinger	director	C/O BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752-1234
Maria Sainz	director	C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Antoine Papiernik	director, 10 percent owner	5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Sofinnova Capital Vii Fcpr	10 percent owner	C/O SOFINNOVA PARTNERS, 18 RUE DU 4 SEPTEMBRE, 75002 PARIS I0 00000
Cahill Colin	director	5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Frederic H Moll	director	C/O INTUITIVE SURGICAL INC, 950 KIFER ROAD, SUNNYVALE CA 94086
James E Flynn	10 percent owner, other: Possible Member of 10% Group	780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Larkin C Raymond Jr	director	C/O MALLINCKRODT INC, 7733 FORSYTH BLVD, ST LOUIS MO 63105